Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.
ACS Chem Biol. 2021 May 21;16(5):800-805. doi: 10.1021/acschembio.0c00894. Epub 2021 Apr 20.
In light of the continued threat of antimicrobial-resistant bacteria, new strategies to expand the repertoire of antimicrobial compounds are necessary. Prodrugs are an underexploited strategy in this effort. Here, we report on the enhanced antimicrobial activity of a prodrug toward bacteria having an enzyme capable of its activation. A screen led us to the sulfurol ester of the antibiotic -3-(4-chlorobenzoyl)acrylic acid. An endogenous esterase makes sensitive to this prodrug. Candidate esterases were identified, and their heterologous production made sensitive to the ester prodrug. Taken together, these data suggest a new approach to the development of antimicrobial compounds that takes advantage of endogenous enzymatic activities to target specific bacteria.
鉴于抗菌耐药菌的持续威胁,有必要制定新策略来扩大抗菌化合物的种类。前药是这方面一种尚未充分利用的策略。在这里,我们报告了一种前药针对具有能够激活该前药的酶的细菌的增强的抗菌活性。筛选导致了抗生素 -3-(4-氯苯甲酰)丙烯酸的磺基酯。一种内源性酯酶使 对该前药敏感。鉴定了候选酯酶,并通过异源生产使 对酯前药敏感。这些数据表明,一种新的开发抗菌化合物的方法利用内源性酶活性来靶向特定细菌。